Abstract
Introduction
Women treated for breast cancer are at increased risk for developing second or new cancers. This study examined behavioral and health care utilization practices associated with screening behaviors for mammography, Papanicolaou (Pap), home fecal occult blood test (FOBT) and endoscopy (flexible sigmoidoscopy, colonoscopy, proctoscopy) among racially and ethnically diverse female breast cancer survivors (BCS) and women without a cancer history.
Methods
Data from the 2001 and 2003 California Health Interview Survey (CHIS), a random-digit dial population-based survey of adult respondents was used to examine self-reported screening practices of BCS (n = 1,502) and women without a cancer history (n = 31,911).
Results
Compared to women without a cancer history, BCS reported more recent screening for all tests. Among BCS, Hispanics reported lowest screening for routine mammography (84.2% versus 68.9%; P < 0.05) but highest screening for Pap test (95.4% versus 85.4%; P > 0.01). White and Asian BCS reported more endoscopic examinations (58.9% versus 46.5%; P < 0.001; 61.2% versus 38.4%; P < 0.05) than the comparison population. After adjustment for demographic, socioeconomic, and health status differences, screening rates for BCS showed higher mammography use (odds ratio [OR] 1.97; 95% confidence interval [95% CI] 1.58–2.46), Pap test (OR 1.44; 95% CI 1.22–1.70), and endoscopic use (OR 1.35; 95% CI 1.16–1.58), but not higher for FOBT.
Conclusions
Even though BCS generally had higher cancer screening rates than women without a cancer history, racial/ethnic differences exist among the type of test received. Narrowing these differences is essential to lessen disparities.
Implications for cancer survivors
The need for screening guidelines for BCS remains a high priority. Survivors would benefit from the frequency of screening for all cancers post-treatment.
Similar content being viewed by others
References
Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711–42.
Ries LAG, Melbert D, Karpcho M, Stinchcomb D, Howlander N, Horner MJ, et al (eds). SEER cancer statistics review, 1975–2005, National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER Web site, 2008. Web site: http://seer.cancer.gov/csr/1975_2005. Accessed July 21, 2009.
Earle CC, Burstein HJ, Winer EP, Weeks J. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.
Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. JNCI Cancer Spectrum. 2005;97(19):1407–27.
Ries L, Eisner M, Kosary C, et al. SEER cancer statistics review, 1975–2001. Bethesda: National Cancer Institute; 2005. Web Site: http://seer.cancer.gov/csr/1975_2001/. Accessed July 21, 2009.
Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998. Update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080–2.
National Comprehensive Cancer Network. Clinical practice guidelines in oncology. V.2.2008 Breast cancer screening and diagnosis guidelines. 2008. Web Site: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed July 21, 2009.
Andersen RM, Urban N. The use of mammography by survivors of breast cancer. Am J Pub Health. 1998;88:1713–5.
Phillips KA, Morrison KR, Andersen R, Aday LA. Understanding the context of health care utilization: assessing environmental and provider-related variables in the behavioral model of utilization. HSR. 1998;33:571–96.
Aday LA, Andersen R. A framework for the study of access to medical care. HSR. 1974;9:208–20.
Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women’s adherence to mammography screening guidelines. HSR. 1998;33:29–53.
Phillips KA, Haas JS, Su-Ying L, Baker LC, Tye S, Kerlikowske K, et al. Are gatekeeper requirements associated with cancer screening utilization? HSR. 2004;39:153–78.
Liang SY, Phillips KA, Nagamine M, Ladabaum U, Haas JS. Rates and predictors of colorectal cancer screening. Prevent Chronic Disease. 2006;3:1–13.
Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care. 2001;39:945–55.
Mandleblatt JS, Lawrence WF, Cullen J, Stanton AL, Krupnick JL, Kwan L, et al. Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol. 2006;24:77–84.
Silliman RA, Ganz PA. Adjuvant chemotherapy use and outcomes in older women with breast cancer: what have we learned? J Clin Oncol. 2006;20(24):2697–9.
Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, et al. Screening practices in cancer survivors. J Cancer Surviv. 2007;1:17–26.
Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.
Trask PC, Rabin C, Rogers ML, Whiteley J, Nash J, Frierson G, et al. Cancer screening practices among cancer survivors. Am J Prev Med. 2005;4:351–6.
Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Beh. 1995;36:1–10.
Taylor R, Davis P, Boyages J. Long-term survival of women with breast cancer in New South Wales. Eur J Cancer. 2003;39:215–22.
Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet. 2002;359:909–19.
Hatteville L, Mahe C, Hill C. Prediction of the long-term survival in breast cancer patients according to the present oncological status. Stat Med. 2002;21:2345–54.
Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, et al. 14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening. Lancet. 1999;353:1903–8.
Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23:276–92.
Soerjomataram I, Louwman WJ, Duijm LEM, Coebergh JWW. Rising incidence of breast cancer among female cancer survivors: implications for surveillance. Br J Cancer, Web Site: http://www.nature.com/bjc/journal/vaop/ncurrent/full/6604816a.html. Accessed July 21, 2009.
Lash TL, Fox MP, Buist DS, Wei F, Field TS, Frost FJ, et al. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;20(25):3001–6.
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23:8884–93.
Field TS, Doubeni C, Fox MP. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23:158–63.
Doubeni CA, Field TS, Yood MU, Rolnick SJ, Quessenberry CP, Fouayzi H, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–8.
Sepucha KR, Belkora JK, Mutchnick S, Esserman LJ. Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. J Clin Oncol. 2002;20:2695–700.
Sepucha KR, Fowler FJ, Mulley AJ. Policy support for patient-centered care: the need for measurable improvements in decision quality. Health Affairs, 2004: Supp. Web Exclusive VAR: 54–62. Web site: http://www.healthaffairs.org. Accessed July 21, 2009.
National Comprehensive Cancer Network: NCCN practice guidelines in oncology, V1.2005. Web site: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed July 21, 2009.
Ponce NA, Lavarreda SA, Yen W, Brown ER, DiSogra C, Satter DE. The California Health Interview Survey 2001: translation of a major survey for California’s multiethnic population. Public Health Rep. 2004;119:388–93.
Sheinfeld Gorin S, Gauthier J, Hay J, Miles A, Wardel J. Cancer screening and aging: research barriers and opportunities. Cancer. 2008;113(12 Suppl):3493–504.
Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet. 2000;355:395–9.
Burnstein HJ, Winer EP. Primary care for survivors of breast cancer. NEJM. 2000;343:1086–94.
Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–9.
Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2007;25:1074–81.
Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999;17:1080–2.
Institute of Medicine Report. Ensuring quality cancer care. In: Hewitt M, Simone JV, editors. National cancer policy board, institute of medicine report and national research council. Washington: National Academy; 1999.
California Health Interview Survey. CHIS 2001 methodology series, report 1: sample design. 2002. Web site: http://www.chis.ucla.edu/methods.html. Accessed July 21, 2009.
California Health Interview Survey. CHIS 2003 methodology series, report 1: sample design. 2005. Web site: http://www.chis.ucla.edu/methods.html). Accessed July 21, 2009.
California Health Interview Survey. CHIS methodology series: inference using cross sectional surveys for multiple years. 2006. Web site: http://www.chis.ucla.edu/methods.html. Accessed July 21, 2009.
Screening for Cervical Cancer. January 2003. U.S. Preventive Services Task Force. Agency for Health Care Research and Quality, Rockville, MD. Web site: http://www.ahrq.gov/clinic/uspstf/uspscerv.htm. Accessed July 21, 2009.
Screening for Colorectal Cancer. July 2002. U.S. Preventive Services Task Force. Agency for Health Care Research and Quality, Rockville, MD. Web site: http://www.ahrq.gov/clinic/uspstf/uspscol.htm. Accessed July 21, 2009.
Research Triangle Institute. SUDAAN example manual: release 9.0. 2004. Research Triangle Park, NC: Research Triangle Institute.
U.S. Census Bureau, U.S. Department of Commerce, U.S. Hispanic Population Surpasses 45 Million Now 15 Percent of Total. Press Release, May 1, 2008. Web access: http://www.census.gov/Press-Release/www/releases/archives/population/011910.html. Accessed July 21, 2009.
Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. NEJM. 1993;329:326–31.
De Alba I, Hubbell FA, McMullen JM, Sweningson JM, Saitz R. Impact of U.S. citizenship status on cancer screening among immigrant women. J Gen Intern Med. 2005;20:290–6.
Kagawa-Singer M, Pourat N, Breen N, Coughlin S, Abend McLean T, McNeel TS, et al. Breast and cervical cancer screening rates of subgroups of Asian American women in California. Med Care Res Rev. 2007;64:706–30.
Crawley LM, Ahn DK, Winkleby MA. Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Cancer Epidemiol Biomark Prev. 2008;17:1937–44.
Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Liang SY. Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care. 2002;40:743–51.
Ashing-Giwa KT, Padilla G, Tejero J, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Latina and Caucasian cancer survivors. Psychooncology. 2004;13(6):408–28.
Tu SP, Taplin SH, Barlow WE, Boyko EJ. Breast cancer screening by Asian-American women in a managed care environment. Am J Prev Med. 1999;17:55–61.
Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst. 1999;91:1480–6.
Yabroff KR, Lawrence F, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.
Sillman RA, Troyan SL, Guadagnoli E. The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer. 1997;80:1326–34.
Wallace LS, DeVoe JE, Rogers ES, Malagon-Rogers M, Fryer GE. The medical dialogue: disentangling differences between Hispanics and non-Hispanic Whites. J Gen Intern Med. 2007;22:1538–43.
Vogel VG. Identifying and screening patients at risk of second cancers. Cancer Epidemiol Biomark Prev. 2006;15(11):2027–32.
Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomark Prev. 2006;15:2020–6.
Liang SY, Phillips K, Hass J, Sakowski J. Health plan choice and use of cancer screening. Acad Health Serv Res Health Policy Meet. 2002;19:25–9.
Corbie-Smith G, Flagg EW, Doyle JP, O’Brien MA. Influence of usual source of care on differences by race/ethnicity in receipt of preventive services. J Gen Intern Med. 2002;17:458–64.
Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153:299–306.
Acknowledgement
We acknowledge the careful review and contributions of Drs. Taplin and Rowland, and the editorial assistance of Ms. Allison Burness, National Cancer Institute, National Institutes of Health. This paper is dedicated to Dr. Lawrence Breslau (deceased) whose interest and support in this work was ending.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Breslau, E.S., Jeffery, D.D., Davis, W.W. et al. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey. J Cancer Surviv 4, 1–14 (2010). https://doi.org/10.1007/s11764-009-0102-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-009-0102-5